These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 16403405)

  • 21. Myelodysplastic syndromes (refractory anemia). A perspective of the biologic, clinical, and therapeutic issues.
    Besa EC
    Med Clin North Am; 1992 May; 76(3):599-617. PubMed ID: 1578959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging therapeutic strategies for myelodysplastic syndrome.
    Barrett J; Battiwalla M
    Curr Hematol Rep; 2003 May; 2(3):193-201. PubMed ID: 12901340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in MDS.
    Schiffer CA
    Clin Adv Hematol Oncol; 2007 Jun; 5(6):450-2. PubMed ID: 17679919
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic myelomonocytic leukemia: lost in classification?
    Bowen DT
    Hematol Oncol; 2005 Mar; 23(1):26-33. PubMed ID: 16149105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of myelodysplastic syndromes in adults: guidelines from the Belgian Haematological Society.
    Meers S; Breems D; Bries G; Delforge M; Graux C; Ravoet C; Selleslag D; Noens L;
    Acta Clin Belg; 2013; 68(4):253-62. PubMed ID: 24455794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myelodysplastic syndromes in older adults.
    Lindsey M; Beavers J
    Clin J Oncol Nurs; 2010 Oct; 14(5):545-7. PubMed ID: 20880813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [What are the treatment possibilities for myelodysplastic syndrome?].
    von Wichert P
    Internist (Berl); 1995 Jan; 36(1):74-5. PubMed ID: 7883535
    [No Abstract]   [Full Text] [Related]  

  • 28. Myelodysplastic syndromes.
    Scott BL; Deeg HJ
    Annu Rev Med; 2010; 61():345-58. PubMed ID: 20059342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myelodysplasia.
    Heaney ML; Golde DW
    N Engl J Med; 1999 May; 340(21):1649-60. PubMed ID: 10341278
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chronic myelomonocytic leukemia: from diagnosis to treatment].
    Hafraoui K; De Prijck B; Beguin Y
    Rev Med Suisse; 2013 Aug; 9(395):1512, 1514-7. PubMed ID: 24024420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic Literature Review of Treatment Options and Clinical Outcomes for Patients With Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia.
    Bell JA; Galaznik A; Huelin R; Stokes M; Guo Y; Fram RJ; Faller DV
    Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):e157-e166. PubMed ID: 29475821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.
    Valcárcel D; Martino R
    Curr Opin Oncol; 2007 Nov; 19(6):660-6. PubMed ID: 17906468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myelodysplastic syndromes in childhood: description of seven cases.
    Vitale A; Testi AM; Moleti ML; Vignetti M; Arcese W; Fenu S; Cedrone M; De Felice L; Amadori S; Mandelli F
    Ann Hematol; 1994 May; 68(5):241-5. PubMed ID: 8018765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis and clinical variations in the myelodysplastic syndromes.
    Jacobs A; Clark RE
    Clin Haematol; 1986 Nov; 15(4):925-51. PubMed ID: 3552349
    [No Abstract]   [Full Text] [Related]  

  • 35. Consensus statement on iron overload in myelodysplastic syndromes.
    Bennett JM;
    Am J Hematol; 2008 Nov; 83(11):858-61. PubMed ID: 18767130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab.
    Bathini S; Holtzman NG; Koka R; Singh Z; Wilding E; Zou Y; Ruehle K; Kocoglu MH; Badros A; Hardy N; Yared J; Rapoport AP; Fontaine M; Emadi A; El Chaer F; Dahiya S
    Am J Hematol; 2019 Aug; 94(8):E216-E219. PubMed ID: 31120638
    [No Abstract]   [Full Text] [Related]  

  • 37. Myelodysplastic syndromes: clinical practice guidelines in oncology.
    Greenberg PL; Attar E; Bennett JM; Bloomfield CD; Borate U; De Castro CM; Deeg HJ; Frankfurt O; Gaensler K; Garcia-Manero G; Gore SD; Head D; Komrokji R; Maness LJ; Millenson M; O'Donnell MR; Shami PJ; Stein BL; Stone RM; Thompson JE; Westervelt P; Wheeler B; Shead DA; Naganuma M
    J Natl Compr Canc Netw; 2013 Jul; 11(7):838-74. PubMed ID: 23847220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
    Greenberg PL; Stone RM; Al-Kali A; Barta SK; Bejar R; Bennett JM; Carraway H; De Castro CM; Deeg HJ; DeZern AE; Fathi AT; Frankfurt O; Gaensler K; Garcia-Manero G; Griffiths EA; Head D; Horsfall R; Johnson RA; Juckett M; Klimek VM; Komrokji R; Kujawski LA; Maness LJ; O'Donnell MR; Pollyea DA; Shami PJ; Stein BL; Walker AR; Westervelt P; Zeidan A; Shead DA; Smith C
    J Natl Compr Canc Netw; 2017 Jan; 15(1):60-87. PubMed ID: 28040720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced-intensity hematopoietic stem cell transplantation for a patient with myelodysplastic syndrome and chronic obstructive pulmonary disease.
    Obama K; Eto T; Tsuruta N; Nagara Y; Okeda A; Kato K; Muta T; Gondo H; Shibuya T
    Int J Hematol; 2004 Dec; 80(5):470-1. PubMed ID: 15646663
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current status and problem of platelet transfusion for hematopoietic diseases: results from a questionnaire survey].
    Kato H; Handa M; Takamoto S
    Rinsho Ketsueki; 2006 Dec; 47(12):1514-20. PubMed ID: 17233469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.